Introduction: The relationship between diabetes and anxiety and depression is bidirectional. Patients with somatic disorders such as diabetes present on average twice more psychiatric disorders than the general population. The aim of our study was to identify the level of anxiety and depression in people with diabetes type 1 and to assess their impact on the clinical features of the disease.
Patients and methods: We conducted a transversal descriptive study including 102 patients with type 1 diabetes, for 8 months (May-December 2017). Assessing anxiety state was made according to the Hamilton and Beck score for depression in Arabic validated. Analysis was performed by SPSS 16.
Results: A mean age was 24 years with, a sex ratio of 1.04 M/F, toxic habits (21.5%), an average diabetes devation of 10.4 years and an uncontrolled diabetes in 83.3% of cases. Degenerative complications were: a retinopathy (20.6%), a nephropathy (20.6%), and neuropathy (16.7%). Incidence of hypoglycemiawas97.05%, irregular follow-up 34.3% of cases. We noted a minor depression (17.6%), a major (11.8%) control glycemia in our patients depression and a minor anxiety (46%) and major (11%). Anxiety was related to degenerative complications (26.4%). Depression was most noticeable among female patients (20.6%) and contributing factors to this were degenerative complications (14.7%) and lack of financial support (13.72%). Anxiety and depression were not correlated with glycemic control. This highly correlated to the monitoring irregularity.
Conclusion: We emphasize as well the need to integrate research of anxiety and depressive disorders in the care of diabetic type 1 patients, in order and delay the onset of complications.
19 - 22 May 2018
European Society of Endocrinology